Effects of azacitidine compared with conventional care regimens in elderly (≥75 years) patients with higher-risk myelodysplastic syndromes-Reference-Cited by-同舟云学术

Effects of azacitidine compared with conventional care regimens in elderly (≥75 years) patients with higher-risk myelodysplastic syndromes

Published:2010-12 Issue:3 Volume:76 Page:218-227
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Seymour John F.,Fenaux Pierre,Silverman Lewis R.,Mufti Ghulam J.,Hellström-Lindberg Eva,Santini Valeria,List Alan F.,Gore Steven D.,Backstrom Jay,McKenzie David,Beach C.L.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference25 articles.

1. The myelodysplastic syndromes;Nguyen;Hematol Oncol Clin N Am,2009

2. Treatment decision making for older patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: problems and approaches;Deschler;Haematologica,2006

3. Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndrome;Sekeres;Leukemia,2004

4. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes;Malcovati;J Clin Oncol,2007

5. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytidine deaminase status as a marker of response to azacytidine treatment in MDS and AML patients;British Journal of Haematology;2023-09-10

2. DNA methyltransferase inhibitor exposure–response: Challenges and opportunities;Clinical and Translational Science;2023-06-21

3. Melatonin: A Potential Regulator of DNA Methylation;Antioxidants;2023-05-25

4. Azacitidine Monotherapy in Patients With Treatment-Naïve Higher-risk Myelodysplastic Syndrome: A Systematic Literature Review and Meta-analysis;Clinical Lymphoma Myeloma and Leukemia;2023-02

5. Clinical impact of transformation to acute myeloid leukemia in patients with higher-risk myelodysplastic syndromes;Future Oncology;2022-11